Hosted on MSN
10 Must-Read Books on Bipolar Disorder From 2025
From lived experience to expert insight, these books open the door to understanding, connection, and new ways of seeing bipolar disorder. Living with bipolar can sometimes feel like you’re trying to ...
Bipolar disorder is a complex psychiatric disorder, characterized by fluctuations between episodes of (hypo)mania and depression. It is estimated to affect around 40 to 50 million people worldwide.
Individuals older than 50 years with bipolar or major depressive disorder were more likely to have retinal disease, and those with a diagnosis of retinal disease and a psychiatric illness were at ...
Bipolar disorder exists on a spectrum rather than as a single, uniform condition. This fundamental characteristic explains why two people with the same diagnosis can experience dramatically different ...
When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...
Zacks Investment Research on MSN
AXSM's 2025 revenue surge largely driven by Auvelity: What's ahead?
Axsome Therapeutics AXSM has been witnessing strong uptake for its lead marketed drug, Auvelity (AXS-05), which is approved ...
Individuals with opioid use disorder can get “stuck” in particular patterns of brain activity, a new Yale study finds. And this stickiness is more pronounced after they’ve seen images related to ...
International Foundation for Gastrointestinal Disorders (IFFGD) launches #LetsTalkGERD, a social campaign raising awareness about Gastroesophageal Reflux Disease (GERD). MOUNT PLEASANT, S.C., Nov. 12, ...
TITUSVILLE, N.J., Nov. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA ® (lumateperone) as an adjunctive therapy ...
Eating disorders represent one of the most misunderstood mental health conditions affecting millions of people across all demographics. While many assume these complex conditions stem from simple ...
TNX-102 SL is a potential first-in-class treatment for targeting the disturbed sleep associated with depression TNX-102 SL is FDA-approved for the treatment of fibromyalgia CHATHAM, N.J., Sept. 18, ...
Dissociative identity disorder is often rooted in chronic childhood trauma. Repeated abuse, neglect, and attachment disruptions can fragment a growing mind. Healing is possible.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results